Activated STING in a vascular and pulmonary syndrome Y Liu, AA Jesus, B Marrero, D Yang, SE Ramsey, ... New England Journal of Medicine 371 (6), 507-518, 2014 | 1261 | 2014 |
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) P Macchi, A Villa, S Giliani, MG Sacco, A Frattini, F Porta, AG Ugazio, ... Nature 377 (6544), 65-68, 1995 | 1041 | 1995 |
Actionable diagnosis of neuroleptospirosis by next-generation sequencing MR Wilson, SN Naccache, E Samayoa, M Biagtan, H Bashir, G Yu, ... New England Journal of Medicine 370 (25), 2408-2417, 2014 | 912 | 2014 |
Early-onset stroke and vasculopathy associated with mutations in ADA2 Q Zhou, D Yang, AK Ombrello, AV Zavialov, C Toro, AV Zavialov, ... New England Journal of Medicine 370 (10), 911-920, 2014 | 822 | 2014 |
Engraftment potential of human amnion and chorion cells derived from term placenta M Bailo, M Soncini, E Vertua, PB Signoroni, S Sanzone, G Lombardi, ... Transplantation 78 (10), 1439-1448, 2004 | 512 | 2004 |
Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans F Candotti, KL Shaw, L Muul, D Carbonaro, R Sokolic, C Choi, ... Blood, The Journal of the American Society of Hematology 120 (18), 3635-3646, 2012 | 282 | 2012 |
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies J Oh, AF Freeman, M Park, R Sokolic, F Candotti, SM Holland, JA Segre, ... Genome research 23 (12), 2103-2114, 2013 | 269 | 2013 |
Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial LM Muul, LM Tuschong, SL Soenen, GJ Jagadeesh, WJ Ramsey, Z Long, ... Blood, The Journal of the American Society of Hematology 101 (7), 2563-2569, 2003 | 268 | 2003 |
How I treat ADA deficiency HB Gaspar, A Aiuti, F Porta, F Candotti, MS Hershfield, LD Notarangelo Blood, The Journal of the American Society of Hematology 114 (17), 3524-3532, 2009 | 260 | 2009 |
Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness C Lagresle-Peyrou, EM Six, C Picard, F Rieux-Laucat, V Michel, A Ditadi, ... Nature genetics 41 (1), 106-111, 2009 | 243 | 2009 |
Structural and functional basis for JAK3-deficient severe combined immunodeficiency F Candotti, SA Oakes, JA Johnston, S Giliani, RF Schumacher, P Mella, ... Blood, The Journal of the American Society of Hematology 90 (10), 3996-4003, 1997 | 227 | 1997 |
Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy L Tuschong, SL Soenen, RM Blaese, F Candotti, LM Muul Human gene therapy 13 (13), 1605-1610, 2002 | 218 | 2002 |
Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome F Candotti Journal of clinical immunology 38 (1), 13-27, 2018 | 204 | 2018 |
X-SCID transgene leukaemogenicity AJ Thrasher, HB Gaspar, C Baum, U Modlich, A Schambach, F Candotti, ... Nature 443 (7109), E5-E6, 2006 | 203 | 2006 |
Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs M Pesu, F Candotti, M Husa, SR Hofmann, LD Notarangelo, JJ O'Shea Immunological reviews 203 (1), 127-142, 2005 | 197 | 2005 |
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency JM Puck, AE Pepper, PS Henthorn, F Candotti, J Isakov, T Whitwam, ... Blood, The Journal of the American Society of Hematology 89 (6), 1968-1977, 1997 | 196 | 1997 |
Transfer of the hsv-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. the san … C Bordignon, C Bonini, S Verzeletti, N Nobili, D Maggioni, C Traversari, ... Human gene therapy 6 (6), 813-819, 1995 | 187 | 1995 |
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases YJ Zhou, M Chen, NA Cusack, LH Kimmel, KS Magnuson, JG Boyd, W Lin, ... Molecular cell 8 (5), 959-969, 2001 | 186 | 2001 |
Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains M Chen, A Cheng, F Candotti, YJ Zhou, A Hymel, A Fasth, ... Molecular and Cellular Biology 20 (3), 947-956, 2000 | 176 | 2000 |
Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism T Wada, SH Schurman, M Otsu, EK Garabedian, HD Ochs, DL Nelson, ... Proceedings of the National Academy of Sciences 98 (15), 8697-8702, 2001 | 171 | 2001 |